CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $26,552,861
- in 2 filings, $26.6M under 10b5-1 plans
Net −$26,552,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-16 | Liu David Y Chief R&D Strategy Officer | Option exercise | +35,331 | $4.21 | $149K | 167,590 |
| 2022-11-16 | Liu David Y Chief R&D Strategy Officer | Option exercise · Stock Option (right to buy) | −13,767 | 0 | ||
| 2022-11-16 | Liu David Y Chief R&D Strategy Officer | Option exercise · Stock Option (right to buy) | −9,726 | 0 | ||
| 2022-11-16 | Liu David Y Chief R&D Strategy Officer | Option exercise · Stock Option (right to buy) | −5,999 | 0 | ||
| 2022-11-16 | Liu David Y Chief R&D Strategy Officer | Option exercise · Stock Option (right to buy) | −35,656 | 0 | ||
| 2022-11-16 | Liu David Y Chief R&D Strategy Officer | Option exercise · Stock Option (right to buy) | −35,331 | 0 | ||
| 2022-11-15 | MOLINA ARTURO MD Chief Medical Officer | Grant or award | +21,250 | 21,250 | ||
| 2022-11-15 | MOLINA ARTURO MD Chief Medical Officer | Grant or award · Stock Option (right to buy) | +127,500 | 127,500 | ||
| 2022-08-23 | PATEL DINESH V PH D President and CEO | Option exercise | +20,000 | $4.21 | $84K | 604,048 |
| 2022-08-23 | PATEL DINESH V PH D President and CEO | Option exercise · Stock Option (right to buy) | −20,000 | 60,000 | ||
| 2022-05-26 | Waddill William D. Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-05-26 | O'Dowd Sarah A Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-05-26 | Noonberg Sarah B. Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-05-26 | Williams Lewis T Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-05-26 | SELICK HAROLD E Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-05-26 | Giraudo Bryan Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-05-04 | PATEL DINESH V PH D President and CEO | Gift | −3,000 | 581,048 | ||
| 2022-05-04 | PATEL DINESH V PH D President and CEO | Option exercise | +15,742 | $4.21 | $66K | 584,048 |
| 2022-05-04 | PATEL DINESH V PH D President and CEO | Option exercise · Stock Option (right to buy) | −15,742 | 80,000 | ||
| 2022-05-03 | Waddill William D. Director | Option exercise | +12,000 | $8.59 | $103K | 12,000 |
Page 16 of 29 · 580 trades